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Abstract
Background: Klebsiella species are widely present in the environment 
and colonize mucosal surfaces of humans. The organism is responsible 
for various community and hospital-acquired infections. The increased 
incidence of isolates producing K. pneumoniae carbapenemases 
(KPCs) in infected patients became a significant problem in many 
countries, especially those new hypervirulent clinical variant (hvKp). 
This prospective study was intended to detect the incidence, virulence 
factors and carbapenems resistant gene (blakpc2) in K. pneumoniae 
isolates among Jordanian patients.
Methods: A total of 104 klebsiella species isolates were collected 
randomly from three major hospitals in Amman, Jordan, over the 
period from September 2013 to October 2014. These isolates were 
investigated for incidence of K. pneumoniae, antimicrobial susceptibility 
and detection of virulence factors and kpc gene using PCR .
Results: A total of 75 (72%) of the collected isolates were confirmed 
as K. pneumoniae using PCR, and 74% of these were MDR to at 
least 3 antibiotic classes. The percentage of the virulence factors K1, 
K2, K5, rmpA and aerobactin were 0%, 4%, 0%, 5.3% and 10.7%, 
respectively. Resistant to cabapenems was detected in 18/75 (24% ) of 
K . pneumoniae isolates, and 10 (13.3%) of these have the kpc genes . 
Conclusion: This study confirms the high incidence rate of MDR K. 
pneumoniae and low incidence of (KPCs) isolates in Jordanian patients. 
There were few isolates associated with virulence factor hvKp, and 
no significant correlation demonstrated between the presence of 
virulence factors and kpc gene in these isolates.
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Introduction
K. pneumoniae is the most frequent Klebsiella 
species causing community-acquired and nosoco-
mial infections worldwide [1,2]. During the last few 
years clinical isolates of K. pneumoniae produc-
ing carbapenemases (KPCs) became highly multi-
drug resistant (MDR), including the acquisition of 
extended-spectrum b-lactamases (ESBLs) and car-
bapenemases. These b-lactamases are able to hy-
drolyse the carbapenems and confer resistance to 
many other antibiotics. In certain countries, KPCs 
are now considered endemic and many outbreaks 
were recorded in several countries [2]. 
To date, nine different variants (KPC-2–KPC-10) of 
the KPC enzymes have been discovered, with KPC-2 
and KPC-3 were the most frequently recovered from 
clinical specimens [2-3], and re-sequencing of the 
blaKPC-1 gene revealed it to be identical to blaKPC-2 
gene [4]. Furthermore, it has been shown that in-
creased incidence of K. pneumoniae producing car-
bapenemases isolates in association with hypervilu-
ent characteristics in infected patients has caused a 
significant treatment problem [4-5]. 
The new hypervirulent (hyper mucoviscous) clini-
cal variant of K. pneumoniae (hvKp) has been in-
creasingly detected over the last 20 years. The first 
reports about it were from the “Pacific Region”, but 
in recent years more infections caused by hvKp are 
being reported in other countries [5]. Infection due 
to hvKp was clinically first observed as community-
acquired liver abscess (CA-PLA); affecting patients 
lacking a history of hepato biliary disease, and caus-
ing metastatic spread to distant body sites in many 
cases. More recently, hvKp has also been observed 
to cause a variety of serious extrahepatic abscesses, 
primary septicemia, meningitis and endophthalmi-
tis in healthy adults. The organism was also associ-
ated with a significant mortality rate, ranging from 
3–42% [5-6]. 
This study investigated the general incidence of 
MDR K. pneumoniae isolates and their association 
with potential virulence factors causing hvKp infec-
tion in Jordanian patients. 
Material and Methods
Clinical specimens
This prospective study included a total of 104 
klebsiella isolates from clinical specimens of patients 
who were admitted to king Hussein Medical Center, 
Jordan University Hospital (JUH) and Istishari Hospi-
tal in Amman, Jordan, over the period September 
2013 through October 2014.
Data collection.
A biographical data about each patient was ob-
tained and registered on special form. These include 
age, gender, name, disease history, and taking of 
antibiotic at time of sampling and before 2 week 
of sampling. Ethical approval was obtained from 
the Institutional Ethical Committees at the three 
hospitals, and the study was also approved by the 
Deanship of Scientific Research at the University of 
Jordan.
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Klebsiella identification 
All collected klebsiella isolates were sub-cultured 
on MacConkey agar and incubated for 24 hr at 37°C. 
Five colonies that morphologically represent Klebsi-
ella like-growth were selected and sub-cultured on 
MacConkey again to obtain pure Klebsiella isolates 
and later these were tested by commercial Remel 
RapID ONE test (Oxoid, England) at the Microbiol-
ogy Research Laboratories, Faculty of Medicine, The 
Jordan University. A total of 75 isolates were identi-
fied as Klebsiella pneumoniae. 
Antimicrobial Susceptibility Testing
Antimicrobial susceptibility using a disk diffusion 
test was performed on 75 K. pneumoniae according 
to the recommendation of the Clinical Laboratory 
and Standards Institute (CLSI) [7]. The results were 
interpreted according to the guidelines of CLSI. 
Escherichia coli ATCC 25922 was used as control 
for susceptibility test. 
DNA and plasmid extraction
The bacterial DNA was extracted using the Wiz-
ard genomic DNA purification kit (Promega, USA) 
according to the manufacturer’s protocol for isola-
tion of bacterial DNA from gram negative bacte-
ria. The DNA quantity of each extract of Klebsiella 
pneumoniae isolate was tested by spectrophotom-
eter (BioRad, USA) to ensure that the DNA yield is 
significant (>50µg/ml) for PCR test . Extraction of 
pure plasmid DNA was carried out according to the 
Zyppy™ Plasmid Miniprep Kit (alkaline lysis method) 
supplemented by manufactured company (Zyppy™, 
USA). 
Polymerase chain reaction (PCR) and 
product analysis
Three pairs of primers were used to detect genes( 
rpo B, peh X, gyr A), the first one identified K. pne-
moniae, the second one for K. oxytoca, and the last 
one for all klebsiella species as described by Chan-
der et al. [8]. Multiplex PCR was used to identified 
virulence factors (K1, K2, K5, rmpA, and aerobactin) 
among K. pneomoniae isolates as reported by Siu et 
al. [9]. Uniplex PCR was used to identified KPC gene 
in 18 K. pneumoniae isolates which were resistant 
for one or more of ertapenem, imipenem and me-
ropenem as stated by Yigit et al. [10]. A strain of K. 
pneumoniae ATCC BAA-1705 was used as a positive 
control for detection of KPC gene, and nuclease 
free water was used as a negative control.
Sequencing of the blakpc PCR products 
DNA sequencing was performed by Macrogen 
Company (Seoul, Korea) to confirm the detected of 
blakpc gene using KPC primers. 
Statistical analysis
Data were analyzed using Statistical Package for 
Social Sciences (IBM SPSS) version 20. Frequency 
and percentage were calculated for the categori-
cal data, and Pearson’s chi-squared test or Fisher’s 
exact test were applied to determine potential fac-
tors associated with k. pnemoniae and to deter-
mine whether there are any statistical differences 
between virulence factors. The level of significance 
was set at a p value of ≤0.05 to test the hypothesis 
of no association. Fisher’s exact test replaces chi-
squared test when the minimum expected count is 
less than five.
Results
A total 75 K. pneumoniae isolates were examined 
by use of PCR for detection species specific genes 
(rpo B and gyr A.) The distribution of these isolates 
from patients according to the source of specimens, 
the gender and age is shown in Table 1. The ma-
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jority of the isolates (74%) were multidrug resistant 
to ≥ 3 antibiotic classes (Table 2). Few K. pneo-
moniae isolates were positive for virulence factors 
genes of K2 (3; 4%), rmpA (4;5.3% ) and aerobactin 
(10; 10.7%) (Table 3). A total of 10 /75 (7.5%) K. 
pneumoniae isolates were positive for KPC genes. 
Table  4 shows the correlation between the type 
of antibiotics resistance markers and KPC positive 
isolates.
 DNA sequencing of K. pneomoniae isolates posi-
tive for blakpc gene has confirmed the presence of 
blakpc gene using KPC primers (Macrogen Com-
pany (Seoul, Korea). 
Discussion 
This study demonstrates that K. pneomoniae is 
the most common species among Klebsiella isolates 
(72%) from patients in three major hospitals in Am-
man, Jordan. High rate of antimicrobial resistance 
was demonstrated and MDR accounted for 74% 
of the isolates. K. pneomoniae positive for blaKPC 
genes among the isolates was low (13.3%), and all 
these isolates were MDR to 11 tested antimicrobial 
drugs including resistant to imipenim, meropenem. 
These results reflect that K. pneomoniae carbapen-
emases (KPCs) is already causing infections in Jor-
danian patients, since our isolates originating from 
various clinical samples of three major hospitals in 
Amman. This result should be considered as alarm-
ing sign that other Gram-negative enteric bacteria 
causing infection in Jordanian patients may also 
carry blaKPC genes.
K. pneomoniae carbapenemases (KPCs) was first 
reported in USA in the year 2012. Since then, bac-
terial isolates carrying this resistance mechanism 
have frequently detected in other countries [11-12]. 
A recent study from Palestine has describes the first 
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Table 1. Distribution of 75 K. pneumonia from 
patients according to source of specimens*
Specimens No.(%)
Urine 52(69.3)
Wound-pus 14(18.7)
Blood 3(4)
Catheter line 3(4)
Bone 1(1.3)
Drain 1(1.3)
Pleural fluid 1(1.3)
Total 75(100)
*  Males accounted for 50.7% and females for 49.3% (mean age ± 
SD = 34 ± 21.9 years)
Table 2. Antimicrobial susceptibility pattern of 75 K. pneumoniae isolates
No. (%)
Susceptible
AntibioticNo. (%)
Susceptible
Antibiotic
25(33.3)Amikacin58(77.3)Imipenem
24(32)Azetreonam54(72)Meropenem
24(32)Ceftazidime52(69.3)Cefoxitin
24(32)Cotrimoxazole46(61.3)Eterapenem
20(26.7)Ceftriaxone30(40)Gentamicin
18(24)Cefotaxime28(37.7)Tigecyclin
14(18.7)Amoxycilin/ Calvulanate26(34.7)Ciprofloxacin
*A total of 74% were MDR ≥ 3 antibiotic classes
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detection of 3 isolates blaKPC positive E. cloacae 
and one isolates K. pneumoniae in patients, and all 
4 isolates were resistant to all β-lactam antibiotics 
including carbapen ems (ertapenem, imipenem and 
meropenem), co-trimoxazole and gentamicin, while 
these were susceptible to amikacin and colistin [13] . 
Recently, a study from Saudi Arabia reported that 
multi-drug carbapenem-resistant K. pneumoniae in-
fection carrying the OXA-48 gene resulted in an 
outbreak in a tertiary care hospital in Riyadh [14]. 
Additionally, there was a report from Lebanon on 
the first occurrence of oxacillinase-mediated resis-
tance to carbapenems in Klebsiella pneumoniae 
isolates [15]. It is important to note here that car-
bapenemase-mediated resistance to carbapenems 
in K. pneumoniae may be due to KPC, VIM ⁄ IMP 
and OXA-48 in countries surrounding the Mediter-
ranean [15].
A recent study by Shanmugam et al., (2013) in 
India, reported that blaKPC gene was recently de-
tected in clinical isolates of carbapenem resistant 
Enterobacteriaceae in a Tertiary Care Hospital in 
India [16], whereas a study from china has demon-
strated that the majority of carbapenem resistance 
determinants in Enterobacteriaceae (blaKPC−2, 
blaVIM−1,and blaIMP−4 ) were transferable by con-
jugation experiments [17] [Wang et al. 2015]. The 
rapid spread and growing list of pathogens in which 
the blaKPC gene has been isolated is probably due 
to its carriage on plasmids [18]. In addition, a large 
multicentre cohort study in Italy had recently showed 
that infections caused by K. pneumoniae strains ex-
pressing KPC-2 or KPC-3 are associated with a high 
mortality rate, and indicated that combination of 
antimicrobial drugs such as tigecycline, colistin and 
gentamicin that include meropenem can provide 
appreciable therapeutic benefits if the meropenem 
MIC for the KPC-Kp isolate is ≤8 mg/L [19].
The present study showed low distribution of 
the major virulence factors K1, K2, K5, rmpA and 
aerobactin among our 75 K. pneumoniae clinical 
isolates, and only few isolates carried the K2 or 
rmp virulence genes which are frequently present in 
carbapenem-resistant hypervirulent K . pneumoniae 
(HvKP) strains (Table 3). Additionally, HvKp strains 
carried rmpA/rmpA2 genes on large virulence plas-
mid ( 180-220 kb) [5]. 
This finding shows that the prevalence rate of 
HvKp isolates are still low and not significant in 
Jordan comparing with other recent studies from 
china and other countries [19-21]. The occurrence 
of hypervirulent strains of K. pneumoniae (hvKp 
) associated with abscess formation, commonly 
hepatic, and metastatic spread have been increas-
ingly detected over the world, and the manage-
ment of their infections is becoming extremely 
challenging by presence of carbapenem-resis-
tance [5, 20,21]. 
Table 3. Distribution of virulence factors among 
75 K. pneumoniae isolates
Virulence Factor  No. (%)
Correlation 
coefficient Pearson
K1 0 -
K2 3(4)* 0.492
K5 0 -
rmpA 4(5.4)* 0.573
Aerobactin 8(10.7) 0.833
*Associated mostly with hypervirulent K. pneumoniae
Table 4. Incidence of K. pneumoniae producing 
carbapenemases (KPCs) isolates and their 
antimicrobial-resistance markers
Total no. K. 
pneumoniae 
isolates 
No. (%). 
KPCs-positive 
isolates
Antibiotics resistance 
markers
75 10 (13.3) Amikacin Amoxycilin/
Calvulanate 
Azetreonam,Ceftazidime 
Ceftriaxone, 
Cefotaxime,Eterapenem, 
Imepenem,Cefoxitin 
Meropenem Cotrimoxazole 
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